title: Post-marketing surveillance should include effects during pregnancy.
authors.forename: Patricia
authors.initials: P
authors.lastname: Yeargin
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D044966:Anti-Retroviral Agents; D000075202:Contraindications; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced*
chemical_list: D044966:Anti-Retroviral Agents